Funding Received
$59.8 Million in 2 Rounds from 5 Investors
Most Recent Funding
$44.2 Million Series B on December 16, 2009
Founded:
2004
Headquarters:
Zürich
Description:
Molecular Partners focuses on therapeutic, diagnostic, and biotechnological applications of designed ankyrin repeat proteins.
Founders:
Michael Tobias Stumpp
Categories:
Biotechnology
Website:
http://www.molecularpartners.com

Detailed Description

Update

Molecular Partners AG, a biotechnology company, engages in the discovery and development of Designed Ankyrin Repeat Proteins (DARPins) based on the designed repeat protein technology. The company focuses on therapeutic, diagnostic, and biotechnological applications of DARPins. DARPins are binding proteins that show activity against various disease targets, including cell surface receptors, cytokines, proteases, kinases, and viral coat proteins. The company was incorporated in 2004 and is based in Zurich, Switzerland.

Current Team (4)

Update

Past Team (1)

Update

Board Members and Advisors (7)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    Wagistrasse 14

    Zürich-Schlieren

    Zürich, 8952

    CHE

Images (1)

Update
  • A18d4b942af71cc54c8fabf2c497c8d8